DNA Plasmid Manufacturing


To serve the growing global demand for plasmid DNA as a critical raw material, TriLink now offers plasmid manufacturing services designed with mRNA therapeutics in mind. The manufacturing process is engineered to minimize endotoxin and omits the use of RNase during isolation. Supported by TriLink’s revolutionary CleanCap® technology and over 20 years of experience manufacturing modified nucleotides, in-house production of plasmid further optimizes mRNA production and can provide an advantage to fast-track your project timelines.